|
ANKRD40 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.737800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.556180E-03 |
| Normal-vs-Stage2 |
9.189400E-01 |
| Normal-vs-Stage3 |
1.952210E-01 |
| Normal-vs-Stage4 |
2.612200E-02 |
| Stage1-vs-Stage2 |
3.006500E-02 |
| Stage1-vs-Stage3 |
2.32099999999402E-05 |
| Stage1-vs-Stage4 |
1.56900000003457E-06 |
| Stage2-vs-Stage3 |
4.197200E-01 |
| Stage2-vs-Stage4 |
1.535820E-01 |
| Stage3-vs-Stage4 |
3.228200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.169800E-01 |
| Normal-vs-AfricanAmerican |
9.671000E-01 |
| Normal-vs-Asian |
1.443750E-01 |
| Caucasian-vs-AfricanAmerican |
5.836800E-01 |
| Caucasian-vs-Asian |
1.309380E-01 |
| AfricanAmerican-vs-Asian |
1.029590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.124400E-01 |
| Normal-vs-Female |
1.480450E-02 |
| Male-vs-Female |
2.081100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.725000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.059590E-01 |
| Normal-vs-Age(61-80Yrs) |
7.545600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.841800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.585800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.392600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.999200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.427550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.197620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.865800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.222300E-03 |
| Normal-vs-Grade 2 |
1.619180E-03 |
| Normal-vs-Grade 3 |
4.535400E-01 |
| Normal-vs-Grade 4 |
2.997100E-03 |
| Grade 1-vs-Grade 2 |
1.344260E-02 |
| Grade 1-vs-Grade 3 |
3.71650000000612E-05 |
| Grade 1-vs-Grade 4 |
4.90969999988877E-07 |
| Grade 2-vs-Grade 3 |
2.40719999999861E-05 |
| Grade 2-vs-Grade 4 |
7.87480000097318E-08 |
| Grade 3-vs-Grade 4 |
1.404500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.70690000034624E-07 |
| Normal-vs-ccB subtype |
1.283220E-01 |
| ccA subtype-vs-ccB subtype |
3.9193981393737E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.166200E-01 |
| Normal-vs-N1 |
5.107800E-01 |
| N0-vs-N1 |
2.805400E-01 |
|
|
